Revenue Recognition and Contractual Adjustments (Tables)

6 Months Ended

Jun. 30, 2018

Summary of Contract Assets and Liabilities

The following table summarizes the values of contract assets, capitalized commissions and contract liabilities as of June 30, 2018 and December 31, 2017 (in thousands):



	June 30, 2018		December 31, 2017
Current pharma contract asset	$	400	$	541
Long-term pharma contract asset	29		31
Total pharma contract asset	$	429	$	572

Current pharma capitalized commissions	$	264	$	371
Long-term pharma capitalized commissions	574		171
Total pharma capitalized commissions	$	838	$	542

Current pharma contract liability	$	2,155	$	1,406
Long-term pharma contract liability	648		283
Total pharma contract liability	$	2,803	$	1,689

Summary of Disaggregation of Revenue

The following table details the disaggregation of revenue for both the Clinical and Pharma Services Segments (in thousands):



	Three Months Ended June 30,				Six Months Ended June 30,
	2018		2017		2018		2017
Clinical Services:
Client direct billing	$	40,847	$	36,796	$	79,561	$	70,427
Commercial Insurance	8,981		10,124		18,922		21,560
Medicare and Medicaid	9,024		8,403		17,201		16,221
Self-Pay	688		224		827		247
Total Clinical Services	$	59,540	$	55,547	$	116,511	$	108,455
Pharma Services:	8,206		6,717		14,658		11,238
Total Revenue	$	67,746	$	62,264	$	131,169	$	119,693